Charles River Laboratories International (CRL) FY2015 results: revenue $1.4 billion, up 5.1% on the year
Charles River Laboratories International, Inc. (CRL) reported revenue of $1.4 billion for fiscal 2015, the year ended 26 December 2015, up 5.1% on the year before. Net income was $149 million, up 17.8%, and diluted earnings per share $3.13. The figures are the company's own, from the 10-K it filed with the SEC on 12 February 2016.
Revenue
$1.4 billion
+5.1% on the year
FY2008FY2015
Operating margin
15.1%
13.7% a year earlier
FY2008FY2015
Net income
$149 million
+17.8% on the year
FY2008FY2015
Diluted EPS
$3.13
+17.7% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
1,363
1,298
1,166
+5.1%
Cost of revenue
832
825
771
+0.9%
Gross profit
531
473
395
+12.4%
Gross margin
39.0%
36.4%
33.9%
Selling, general and administrative
300
269
226
+11.7%
Operating income
206
178
151
+16.2%
Operating margin
15.1%
13.7%
13.0%
Interest expense
15.1
11.9
21.0
+26.1%
Pre-tax income
195
178
138
+10.0%
Income tax
43.4
47.7
32.9
-9.0%
Effective tax rate
22.2%
26.8%
23.8%
Net income
149
127
103
+17.8%
Net margin
11.0%
9.8%
8.8%
Diluted EPS
$3.13
$2.66
$2.12
+17.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
n/a
251
207
Capital expenditure
63.3
56.9
39.2
+11.1%
Free cash flow
n/a
194
168
Free cash flow margin
n/a
15.0%
14.4%
Depreciation and amortisation
94.9
96.4
96.6
-1.6%
Share-based compensation
40.1
31.0
24.5
+29.3%
Buybacks
117
122
166
-3.7%
Diluted shares, weighted
48m
48m
48m
+0.2%
Shares outstanding at period end
47m
47m
48m
-1.3%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
733
672
641
+9.1%
Non-controlling interest
4.5
3.7
3.1
+20.5%
Redeemable equity
28.0
28.4
20.6
-1.4%
Debt
863
772
663
+11.7%
Other liabilities
440
394
305
+11.7%
Total liabilities and equity
2,068
1,871
1,633
+10.6%
Fixed assets
678
677
676
+0.2%
Goodwill
439
321
231
+36.7%
Intangible assets
281
179
84.5
+57.0%
Investments
53.2
27.0
29.1
+96.9%
Cash and equivalents
118
160
156
-26.3%
Receivables
270
258
221
+4.7%
Inventory
93.7
89.0
89.4
+5.3%
Other assets
136
160
146
-14.9%
Total assets
2,068
1,871
1,633
+10.6%
10-K for the year ended 26 December 2015, filed 12 February 2016: the filing.